Journal of veterinary emergency and critical care最新文献_第2页

Utility of Serum Amyloid A-to-Albumin Ratio in Hospitalized Cats 住院猫血清淀粉样蛋白a与白蛋白比值的应用

IF 1.2 3区农林科学 Q3 VETERINARY SCIENCES

Journal of veterinary emergency and critical care

Pub Date : 2025-10-14 DOI: 10.1111/vec.70047

Alexandra A. Allen, Ian M. DeStefano, Elizabeth A. Rozanski

Objective

To evaluate a point-of-care (POC) feline serum amyloid A (fSAA) assay and to describe how fSAA and the fSAA-to-albumin ratio (SAR) in hospitalized cats correspond with outcome, illness severity, and presence of inflammation or infection.

Design

Prospective observational study.

Setting

University teaching hospital.

Animals

The POC fSAA assay was compared with a reference method in 51 cats. The POC fSAA and SAR were evaluated in 34 hospitalized cats.

Interventions

None.

Measurements and Main Results

The POC fSAA and fSAA measured by reference laboratory methods were correlated (r = 0.72, p ≤ 0.001). For all cats, the median POC fSAA was increased (38.9 mg/L; range: 5.0–200.0 mg/L). The median POC fSAA for cats with positive outcomes (44.2 mg/L; range: 5–200 mg/L) was not different from cats with negative outcomes (23.6 mg/L; range: 5–91.0 mg/L) (p = 0.43). Most cats (28/34 [82.4%]) had increased SAR (median: 1270; range: 120–9010). The median SAR for cats with positive outcomes (1315; range: 120–9010) was not different from cats with negative outcomes (795; range: 130–6650) (p = 0.84). Cats with infection were more likely to have severely increased SAR (defined as >3 times the reference interval) (p < 0.004). Most cats with systemic inflammatory response syndrome (SIRS) had severely increased SAR (12/13 [92.3%]) compared with cats without SIRS (10/21 [42.8%]) (p = 0.008). The mean Acute Patient Physiologic and Laboratory Evaluation score of cats with positive outcomes (40.5 [±8.8]) was lower than in cats with negative outcomes (47.6 [±13.7]) (p = 0.015).

Conclusions

There was agreement between the reference method and the POC fSAA assay. The SAR was increased in cats with infection and SIRS and did not correlate with outcome. fSAA and SAR may be useful in clinical applications and for the detection of infectious and inflammatory diseases in cats.

目的：评估护理点（POC）猫血清淀粉样蛋白a （fSAA）测定，并描述住院猫的fSAA和fSAA与白蛋白比（SAR）如何与预后、疾病严重程度和炎症或感染的存在相对应。设计：前瞻性观察研究。单位：大学教学医院。动物：将51只猫的POC fSAA法与参考方法进行比较。对34只住院猫的POC、fSAA和SAR进行了评估。干预措施:没有。测量结果及主要结果：POC fSAA与参比实验室法测得的fSAA呈正相关（r = 0.72, p≤0.001）。所有猫的POC fSAA中值均升高（38.9 mg/L；范围：5.0-200.0 mg/L）。阳性结果猫的POC fSAA中位数（44.2 mg/L，范围：5-200 mg/L）与阴性结果猫的POC fSAA中位数（23.6 mg/L，范围：5-91.0 mg/L）没有差异（p = 0.43）。大多数猫（28/34[82.4%]）的SAR升高（中位数：1270；范围：120-9010）。阳性结果猫的中位SAR（1315；范围：120-9010）与阴性结果猫的中位SAR（795；范围：130-6650）没有差异（p = 0.84）。感染猫更有可能出现严重的SAR升高（定义为> - 3倍参考区间）(p结论：参考方法与POC fSAA测定方法一致。感染和SIRS的猫的SAR升高，但与结果无关。fSAA和SAR可用于临床应用和检测猫的感染性和炎症性疾病。

{"title":"Utility of Serum Amyloid A-to-Albumin Ratio in Hospitalized Cats","authors":"Alexandra A. Allen, Ian M. DeStefano, Elizabeth A. Rozanski","doi":"10.1111/vec.70047","DOIUrl":"10.1111/vec.70047","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To evaluate a point-of-care (POC) feline serum amyloid A (fSAA) assay and to describe how fSAA and the fSAA-to-albumin ratio (SAR) in hospitalized cats correspond with outcome, illness severity, and presence of inflammation or infection.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Prospective observational study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>University teaching hospital.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Animals</h3>\u0000 \u0000 <p>The POC fSAA assay was compared with a reference method in 51 cats. The POC fSAA and SAR were evaluated in 34 hospitalized cats.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interventions</h3>\u0000 \u0000 <p>None.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements and Main Results</h3>\u0000 \u0000 <p>The POC fSAA and fSAA measured by reference laboratory methods were correlated (<i>r</i> = 0.72, <i>p</i> ≤ 0.001). For all cats, the median POC fSAA was increased (38.9 mg/L; range: 5.0–200.0 mg/L). The median POC fSAA for cats with positive outcomes (44.2 mg/L; range: 5–200 mg/L) was not different from cats with negative outcomes (23.6 mg/L; range: 5–91.0 mg/L) (<i>p</i> = 0.43). Most cats (28/34 [82.4%]) had increased SAR (median: 1270; range: 120–9010). The median SAR for cats with positive outcomes (1315; range: 120–9010) was not different from cats with negative outcomes (795; range: 130–6650) (<i>p</i> = 0.84). Cats with infection were more likely to have severely increased SAR (defined as >3 times the reference interval) (<i>p</i> < 0.004). Most cats with systemic inflammatory response syndrome (SIRS) had severely increased SAR (12/13 [92.3%]) compared with cats without SIRS (10/21 [42.8%]) (<i>p</i> = 0.008). The mean Acute Patient Physiologic and Laboratory Evaluation score of cats with positive outcomes (40.5 [±8.8]) was lower than in cats with negative outcomes (47.6 [±13.7]) (<i>p</i> = 0.015).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>There was agreement between the reference method and the POC fSAA assay. The SAR was increased in cats with infection and SIRS and did not correlate with outcome. fSAA and SAR may be useful in clinical applications and for the detection of infectious and inflammatory diseases in cats.</p>\u0000 </section>\u0000 </div>","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"35 5","pages":"495-501"},"PeriodicalIF":1.2,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145287915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cardiac Tamponade Secondary to Anaphylaxis in a Dog With a Peritoneal–Pericardial Diaphragmatic Hernia 犬腹膜-心包膈疝继发于过敏反应的心脏填塞。

IF 1.2 3区农林科学 Q3 VETERINARY SCIENCES

Journal of veterinary emergency and critical care

Pub Date : 2025-10-14 DOI: 10.1111/vec.70036

Stephanie J. Stromberg, Nicole K. Spurlock, David Szabo, Kristin Barncord

Objective

To describe the clinical presentation, management, and outcome of a dog with a peritoneal–pericardial diaphragmatic hernia and cardiac tamponade thought to be secondary to anaphylaxis.

Case Summary

A 10-year-old spayed female Weimaraner presented for an episode of acute collapse. At the time of presentation, the patient was bright, ambulatory (although limping on the left thoracic limb), and had normal perfusion parameters. A stinger was removed from the left thoracic paw pad, and the patient was treated with diphenhydramine. Thoracic and abdominal point-of-care ultrasound identified mild pericardial effusion and gallbladder wall edema. Mild sedation was administered for cardiac assessment, which identified muffled heart sounds and mild pulsus paradoxus. An echocardiogram demonstrated mild cardiac tamponade and the presence of liver lobes surrounded by fluid that appeared contiguous with the pericardial space. An abdominal ultrasound similarly identified a portion of the liver within the pericardium and gallbladder wall edema with no evidence of hepatic venous dilation. The ventral margin of the diaphragm was indistinct on thoracic radiographs. Pericardial effusion resolved within 24 h, and no further clinical signs were seen. At a recheck echocardiogram 1 week later, the patient was doing well at home, and no pericardial effusion or gallbladder wall edema was seen, although a portion of the liver remained within the pericardium.

New or Unique Information Provided

This report details a previously unreported cause of pericardial effusion.

目的：描述狗的临床表现，管理和结果与腹膜-心包膈疝和心脏填塞被认为是继发于过敏反应。病例总结：一只10岁的雌性威玛犬出现急性衰竭。在就诊时，患者神志清晰，可行走（尽管左胸肢跛行），灌注参数正常。从左胸爪垫取出一根毒刺，并用苯海拉明治疗患者。胸部和腹部即时超声检查发现轻度心包积液和胆囊壁水肿。给予轻度镇静进行心脏评估，确定了心音模糊和轻度矛盾脉。超声心动图显示轻度心包填塞，肝叶周围可见与心包间隙相邻的液体。腹部超声同样发现心包内部分肝脏和胆囊壁水肿，无肝静脉扩张迹象。胸片上膈肌腹侧缘不明显。心包积液在24小时内消失，没有进一步的临床症状。1周后复查超声心动图，患者在家情况良好，心包积液和胆囊壁水肿均未见，但部分肝脏仍在心包内。提供新的或独特的信息：本报告详细介绍了以前未报道的心包积液的原因。

{"title":"Cardiac Tamponade Secondary to Anaphylaxis in a Dog With a Peritoneal–Pericardial Diaphragmatic Hernia","authors":"Stephanie J. Stromberg, Nicole K. Spurlock, David Szabo, Kristin Barncord","doi":"10.1111/vec.70036","DOIUrl":"10.1111/vec.70036","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To describe the clinical presentation, management, and outcome of a dog with a peritoneal–pericardial diaphragmatic hernia and cardiac tamponade thought to be secondary to anaphylaxis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Summary</h3>\u0000 \u0000 <p>A 10-year-old spayed female Weimaraner presented for an episode of acute collapse. At the time of presentation, the patient was bright, ambulatory (although limping on the left thoracic limb), and had normal perfusion parameters. A stinger was removed from the left thoracic paw pad, and the patient was treated with diphenhydramine. Thoracic and abdominal point-of-care ultrasound identified mild pericardial effusion and gallbladder wall edema. Mild sedation was administered for cardiac assessment, which identified muffled heart sounds and mild pulsus paradoxus. An echocardiogram demonstrated mild cardiac tamponade and the presence of liver lobes surrounded by fluid that appeared contiguous with the pericardial space. An abdominal ultrasound similarly identified a portion of the liver within the pericardium and gallbladder wall edema with no evidence of hepatic venous dilation. The ventral margin of the diaphragm was indistinct on thoracic radiographs. Pericardial effusion resolved within 24 h, and no further clinical signs were seen. At a recheck echocardiogram 1 week later, the patient was doing well at home, and no pericardial effusion or gallbladder wall edema was seen, although a portion of the liver remained within the pericardium.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> New or Unique Information Provided</h3>\u0000 \u0000 <p>This report details a previously unreported cause of pericardial effusion.</p>\u0000 </section>\u0000 </div>","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"35 5","pages":"589-593"},"PeriodicalIF":1.2,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145287843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Retrospective Evaluation of Blood Product Transfusion Outcomes and Risk Factors for Transfusion Reactions in Dogs at a Veterinary Teaching Hospital With an Established Blood Bank: 137 Dogs (2018–2022) 某建立血库的兽医教学医院犬血制品输血结局及输血反应危险因素回顾性评价：137只犬（2018-2022）

IF 1.2 3区农林科学 Q3 VETERINARY SCIENCES

Journal of veterinary emergency and critical care

Pub Date : 2025-10-10 DOI: 10.1111/vec.70034

Neline G. Holm, Lise N. Nielsen, Rebecca Langhorn

<div> <section> <h3> Objective</h3> <p>To evaluate the outcome of blood transfusions in dogs and identify the incidence of and risk factors associated with transfusion reactions (TRs) classified according to the Association of Veterinary Hematology and Transfusion Medicine (AVHTM) consensus.</p> </section> <section> <h3> Design</h3> <p>Retrospective cross-sectional study with cohort analysis, January 2018–March 2022.</p> </section> <section> <h3> Setting</h3> <p>Veterinary teaching hospital with a well-established blood bank.</p> </section> <section> <h3> Animals</h3> <p>One hundred thirty-seven dogs.</p> </section> <section> <h3> Interventions</h3> <p>None.</p> </section> <section> <h3> Measurements and Main Results</h3> <p>Medical records and transfusion logs of dogs receiving blood transfusions were reviewed. Transfusion outcomes and TRs were assessed according to predefined definitions, TRs as classified by the AVHTM consensus. Two hundred seventeen transfused units (TUs) and 190 transfusion events were documented. Transfusion outcome was successful for 29.5%, moderately improved for 23.7%, and not improved for 9.4% transfusions. The definitions proved especially informative when applied to indications for which a large number of patients received blood products, showing that transfusions generally improved clinical and laboratory parameters in anemia, hypoalbuminemia, and hemostatic dysfunction associated with angiostrongylosis. TRs occurred in 12.4% patients, the most common being an acute hemolytic TR (13/21 of all TRs [61.9%]). TR imputability (cause) was definite for 3 of 21 (14.2%), probable for 16 (76.2%), and possible for 2 (9.6%) TUs. TRs were more common with red blood cell (RBC)-containing products (<i>p</i> ≤ 0.0001) and in dogs with immune-mediated hemolytic anemia (IMHA) (<i>p</i> = 0.002). No associations were found between TRs and administered dose (<i>p</i> = 0.8), transfusion rate (<i>p </i>= 0.053), packed RBC age (<i>p </i>= 0.3), or patient transfusion history (<i>p</i> = 0.3). There were more successful outcomes for transfusions without a TR (<i>p</i> = 0.008; odds ratio: 6.3, 95% confidence interval: 1.6–28.6).</p> </section> <section> <h3> Conclusions</h3> <p>Using established outcome definitions, outcome was successful

目的：评价犬输血后的预后，根据兽医血液学与输血医学协会（AVHTM）共识，确定输血反应（TRs）的发生率及相关危险因素。设计：回顾性横断面研究与队列分析，2018年1月至2022年3月。环境：兽医教学医院，拥有完善的血库。动物：137只狗。干预措施:没有。测量方法和主要结果：回顾了接受输血的犬的医疗记录和输血日志。输血结果和TRs根据预定义的定义进行评估，TRs根据AVHTM共识进行分类。记录了217个输血单位（TUs）和190个输血事件。29.5%的输注成功，23.7%的输注中度改善，9.4%的输注无改善。当应用于大量患者接受血液制品的适应症时，这些定义被证明是特别有用的，表明输血通常改善了与血管线虫病相关的贫血、低白蛋白血症和止血功能障碍的临床和实验室参数。12.4%的患者发生TRs，最常见的是急性溶血性TR（占所有TRs的13/21[61.9%]）。21例患者中有3例（14.2%）可归责（原因），16例（76.2%）可能归责（原因），2例（9.6%）可能归责（原因）。TRs更常见于含红细胞（RBC）的产品（p≤0.0001）和免疫介导的溶血性贫血（IMHA）犬（p = 0.002）。TRs与给药剂量（p = 0.8）、输血率（p = 0.053）、红细胞积液年龄（p = 0.3）或患者输血史（p = 0.3）之间无关联。没有TR的输注有更多的成功结果（p = 0.008；优势比：6.3,95%可信区间：1.6-28.6）。结论：使用既定的结局定义，29.5%的患者结局成功。当使用含红细胞产品时，以及在患有IMHA的犬中，TRs更为常见。

{"title":"Retrospective Evaluation of Blood Product Transfusion Outcomes and Risk Factors for Transfusion Reactions in Dogs at a Veterinary Teaching Hospital With an Established Blood Bank: 137 Dogs (2018–2022)","authors":"Neline G. Holm, Lise N. Nielsen, Rebecca Langhorn","doi":"10.1111/vec.70034","DOIUrl":"10.1111/vec.70034","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To evaluate the outcome of blood transfusions in dogs and identify the incidence of and risk factors associated with transfusion reactions (TRs) classified according to the Association of Veterinary Hematology and Transfusion Medicine (AVHTM) consensus.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Retrospective cross-sectional study with cohort analysis, January 2018–March 2022.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>Veterinary teaching hospital with a well-established blood bank.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Animals</h3>\u0000 \u0000 <p>One hundred thirty-seven dogs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interventions</h3>\u0000 \u0000 <p>None.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements and Main Results</h3>\u0000 \u0000 <p>Medical records and transfusion logs of dogs receiving blood transfusions were reviewed. Transfusion outcomes and TRs were assessed according to predefined definitions, TRs as classified by the AVHTM consensus. Two hundred seventeen transfused units (TUs) and 190 transfusion events were documented. Transfusion outcome was successful for 29.5%, moderately improved for 23.7%, and not improved for 9.4% transfusions. The definitions proved especially informative when applied to indications for which a large number of patients received blood products, showing that transfusions generally improved clinical and laboratory parameters in anemia, hypoalbuminemia, and hemostatic dysfunction associated with angiostrongylosis. TRs occurred in 12.4% patients, the most common being an acute hemolytic TR (13/21 of all TRs [61.9%]). TR imputability (cause) was definite for 3 of 21 (14.2%), probable for 16 (76.2%), and possible for 2 (9.6%) TUs. TRs were more common with red blood cell (RBC)-containing products (<i>p</i> ≤ 0.0001) and in dogs with immune-mediated hemolytic anemia (IMHA) (<i>p</i> = 0.002). No associations were found between TRs and administered dose (<i>p</i> = 0.8), transfusion rate (<i>p </i>= 0.053), packed RBC age (<i>p </i>= 0.3), or patient transfusion history (<i>p</i> = 0.3). There were more successful outcomes for transfusions without a TR (<i>p</i> = 0.008; odds ratio: 6.3, 95% confidence interval: 1.6–28.6).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Using established outcome definitions, outcome was successful ","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"35 5","pages":"551-563"},"PeriodicalIF":1.2,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/vec.70034","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Veterinary Technician Specialists: Perceptions and Experiences Related to VTS Credentials and Skill Utilization 兽医技术专家：与VTS证书和技能利用相关的看法和经验。

IF 1.2 3区农林科学 Q3 VETERINARY SCIENCES

Journal of veterinary emergency and critical care

Pub Date : 2025-10-07 DOI: 10.1111/vec.70039

Lori R. Kogan, Leslie Carter, Kelly Foltz

<div> <section> <h3> Objective</h3> <p>To examine the motivations of veterinary technician specialists (VTSs) in pursuing advanced credentials, the impact of having their VTS credential(s), and their views surrounding the potential barriers to optimal utilization of VTS skill and knowledge.</p> </section> <section> <h3> Design</h3> <p>Electronic survey distributed via veterinary organizations, associations, and social media from December 2023 through May 2024.</p> </section> <section> <h3> Participants</h3> <p>A total of 577 veterinary technician and nurse specialists.</p> </section> <section> <h3> Setting and Interventions</h3> <p>Online survey.</p> </section> <section> <h3> Measurement and Main Results</h3> <p>A total of 577 participants completed the survey. Factor analysis identified four items associated with reasons to become credentialed as a VTS (in descending order of importance): expanded responsibilities, personal growth, recognition/respect, and external influences. Five elements of potential change after earning the VTS credential were also identified (in descending order of prevalence): personal growth, professional recognition/respect, expanded responsibilities, elevated role, and career growth. A total of 76.4% of participants indicated that they had received a pay increase after obtaining the VTS credential; 77.4% reported the increase was ≤10%. A total of 84.2% of participants stated feeling that VTSs are underutilized in the workplace.</p> </section> <section> <h3> Conclusions</h3> <p>The prime motivator for participants to earn the VTS credential was to expand their role and responsibilities; however, many did not experience significant changes in responsibility or scope of clinical practice after receiving their credentials. Most participants felt that VTSs are underutilized, with a lack of role clarity and differentiation from non-VTS colleagues identified as the largest barrier. There is a clear need for better role clarification and an opportunity for education of both veterinary professionals and clients regarding the role, education, and training of VTSs. Although the majority of VTSs recommend the credential to others, it is unclear whether completion of the VTS leads to a commensurate expansion of responsibilities and improvement in compensation that increase the engagement, retention, and career satisfaction of these te

目的：探讨兽医技术专家（VTS）追求高级证书的动机，获得VTS证书的影响，以及他们对最佳利用VTS技能和知识的潜在障碍的看法。设计：从2023年12月到2024年5月，通过兽医组织、协会和社交媒体进行电子调查。参与者：共577名兽医技师和专科护士。设置和干预措施：在线调查。测量及主要结果：共有577名参与者完成了调查。因素分析确定了四个与成为VTS相关的原因（按重要性降序排列）：扩大的责任、个人成长、认可/尊重和外部影响。在获得VTS证书后，还确定了五个潜在的变化要素（按流行程度降序排列）：个人成长、专业认可/尊重、扩大的责任、提升的角色和职业发展。共有76.4%的受访者表示，他们在获得VTS证书后获得加薪；77.4%的人报告增幅≤10%。共有84.2%的参与者表示，VTSs在工作场所没有得到充分利用。结论：被试获得VTS证书的主要动机是扩大自己的角色和责任；然而，许多人在获得证书后并没有经历重大的责任或临床实践范围的变化。大多数与会者认为，vts未得到充分利用，最大的障碍是角色不明确，与非vts同事没有区别。显然，需要更好地明确角色，并为兽医专业人员和客户提供有关VTSs角色、教育和培训的教育机会。虽然大多数VTS向其他人推荐证书，但目前尚不清楚完成VTS是否会导致责任的相应扩大和薪酬的改善，从而增加这些技术人员/护士的参与度、留任率和职业满意度。

{"title":"Veterinary Technician Specialists: Perceptions and Experiences Related to VTS Credentials and Skill Utilization","authors":"Lori R. Kogan, Leslie Carter, Kelly Foltz","doi":"10.1111/vec.70039","DOIUrl":"10.1111/vec.70039","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To examine the motivations of veterinary technician specialists (VTSs) in pursuing advanced credentials, the impact of having their VTS credential(s), and their views surrounding the potential barriers to optimal utilization of VTS skill and knowledge.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Electronic survey distributed via veterinary organizations, associations, and social media from December 2023 through May 2024.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Participants</h3>\u0000 \u0000 <p>A total of 577 veterinary technician and nurse specialists.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting and Interventions</h3>\u0000 \u0000 <p>Online survey.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurement and Main Results</h3>\u0000 \u0000 <p>A total of 577 participants completed the survey. Factor analysis identified four items associated with reasons to become credentialed as a VTS (in descending order of importance): expanded responsibilities, personal growth, recognition/respect, and external influences. Five elements of potential change after earning the VTS credential were also identified (in descending order of prevalence): personal growth, professional recognition/respect, expanded responsibilities, elevated role, and career growth. A total of 76.4% of participants indicated that they had received a pay increase after obtaining the VTS credential; 77.4% reported the increase was ≤10%. A total of 84.2% of participants stated feeling that VTSs are underutilized in the workplace.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The prime motivator for participants to earn the VTS credential was to expand their role and responsibilities; however, many did not experience significant changes in responsibility or scope of clinical practice after receiving their credentials. Most participants felt that VTSs are underutilized, with a lack of role clarity and differentiation from non-VTS colleagues identified as the largest barrier. There is a clear need for better role clarification and an opportunity for education of both veterinary professionals and clients regarding the role, education, and training of VTSs. Although the majority of VTSs recommend the credential to others, it is unclear whether completion of the VTS leads to a commensurate expansion of responsibilities and improvement in compensation that increase the engagement, retention, and career satisfaction of these te","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"35 5","pages":"533-545"},"PeriodicalIF":1.2,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/vec.70039","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Retrospective Evaluation of the Incidence and Risk Factors Associated With the Development of a Hepatopathy in Xylitol Ingestion: 95 Dogs (2018–2022) 95只犬（2018-2022）木糖醇摄入导致肝病的发生率及相关危险因素的回顾性评估

IF 1.2 3区农林科学 Q3 VETERINARY SCIENCES

Journal of veterinary emergency and critical care

Pub Date : 2025-10-07 DOI: 10.1111/vec.70041

Tyler Lovell, Katherine Peterson, Debosmita Kundu, Jonathan P. Mochel, Rebecca A. L. Walton

Objective

To evaluate the association between patient history, clinical signs, decontamination methods, and initial point-of-care diagnostics and the development of hepatotoxicity in dogs with xylitol ingestion.

Design

Retrospective study between 2018 and 2022.

Setting

University veterinary teaching hospital and private practice emergency hospital.

Animals

Ninety-five dogs evaluated by a university veterinary teaching hospital and private practice hospital following xylitol ingestion.

Measurements and main results

Medical records were retrospectively reviewed; signalment, time of ingestion, dose of xylitol ingested, source of xylitol, clinical signs at the time of presentation, and decontamination methods including induction of emesis and administration of activated charcoal were recorded. Point-of-care diagnostics, including PCV and total plasma protein (TP), lactate, blood glucose (BG), and potassium concentrations, were recorded. In total, 47 dogs (49.5%) developed a hepatopathy, 48 dogs (50.5%) did not develop hepatopathy, and no dog developed evidence of hepatic failure. The dose of xylitol ingested was not associated with development of hepatopathy. Dogs that had clinical signs prior to presentation were 1.95 times more likely to develop a hepatopathy than dogs that did not have clinical signs prior to presentation (p = 0.0005). Emesis was induced in 77% of dogs, and dogs that had emesis induced were less likely to develop a hepatopathy than those in which emesis was not induced (p = 0.01). Hypokalemia on presentation was associated with the development of a hepatopathy (p = 0.0353).

Conclusions

This study demonstrates an association between the development of a hepatopathy in dogs and clinical signs prior to presentation, lack of emesis, and hypokalemia on presentation.

目的：评价木糖醇摄入犬的病史、临床症状、去污方法和初始点诊断与肝毒性发展的关系。设计：2018 - 2022年的回顾性研究。单位：大学兽医教学医院和私人执业急救医院。动物：95只狗在木糖醇摄入后由大学兽医教学医院和私人执业医院进行评估。测量结果和主要结果：回顾性回顾了医疗记录；记录信号、摄入时间、摄入木糖醇的剂量、木糖醇的来源、出现时的临床症状以及净化方法，包括诱导呕吐和给药活性炭。记录即时诊断，包括PCV和总血浆蛋白（TP）、乳酸、血糖（BG）和钾浓度。总共有47只狗（49.5%）出现了肝病，48只狗（50.5%）没有出现肝病，没有狗出现肝功能衰竭的迹象。摄入木糖醇的剂量与肝病的发展无关。发病前有临床症状的狗患肝病的可能性是发病前没有临床症状的狗的1.95倍（p = 0.0005）。77%的狗诱导了呕吐，诱导呕吐的狗比未诱导呕吐的狗更不容易发生肝病（p = 0.01）。出现时的低钾血症与肝病的发展相关（p = 0.0353）。结论：本研究表明犬肝病的发展与发病前的临床症状、呕吐不足和发病时的低钾血症之间存在关联。

{"title":"Retrospective Evaluation of the Incidence and Risk Factors Associated With the Development of a Hepatopathy in Xylitol Ingestion: 95 Dogs (2018–2022)","authors":"Tyler Lovell, Katherine Peterson, Debosmita Kundu, Jonathan P. Mochel, Rebecca A. L. Walton","doi":"10.1111/vec.70041","DOIUrl":"10.1111/vec.70041","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To evaluate the association between patient history, clinical signs, decontamination methods, and initial point-of-care diagnostics and the development of hepatotoxicity in dogs with xylitol ingestion.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Retrospective study between 2018 and 2022.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>University veterinary teaching hospital and private practice emergency hospital.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Animals</h3>\u0000 \u0000 <p>Ninety-five dogs evaluated by a university veterinary teaching hospital and private practice hospital following xylitol ingestion.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements and main results</h3>\u0000 \u0000 <p>Medical records were retrospectively reviewed; signalment, time of ingestion, dose of xylitol ingested, source of xylitol, clinical signs at the time of presentation, and decontamination methods including induction of emesis and administration of activated charcoal were recorded. Point-of-care diagnostics, including PCV and total plasma protein (TP), lactate, blood glucose (BG), and potassium concentrations, were recorded. In total, 47 dogs (49.5%) developed a hepatopathy, 48 dogs (50.5%) did not develop hepatopathy, and no dog developed evidence of hepatic failure. The dose of xylitol ingested was not associated with development of hepatopathy. Dogs that had clinical signs prior to presentation were 1.95 times more likely to develop a hepatopathy than dogs that did not have clinical signs prior to presentation (<i>p</i> = 0.0005). Emesis was induced in 77% of dogs, and dogs that had emesis induced were less likely to develop a hepatopathy than those in which emesis was not induced (<i>p</i> = 0.01). Hypokalemia on presentation was associated with the development of a hepatopathy (<i>p</i> = 0.0353).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This study demonstrates an association between the development of a hepatopathy in dogs and clinical signs prior to presentation, lack of emesis, and hypokalemia on presentation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"35 5","pages":"571-576"},"PeriodicalIF":1.2,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Retrospective Evaluation of Cryoprecipitate Transfusion in Dogs to Prevent or Treat Hemorrhage: 21 Cases (2009–2023) 犬低温沉淀输注预防或治疗出血21例回顾性分析（2009-2023）。

IF 1.2 3区农林科学 Q3 VETERINARY SCIENCES

Journal of veterinary emergency and critical care

Pub Date : 2025-10-07 DOI: 10.1111/vec.70045

W. Y. Eunice Lam, Linda G. Martin, K. Jane Wardrop, Jillian M. Haines

<div> <section> <h3> Objective</h3> <p>To report homologous cryoprecipitate transfusions in dogs with hemostatic disorders, hemorrhage, or risk of hemorrhage, and to report adverse reactions associated with these cryoprecipitate transfusions.</p> </section> <section> <h3> Design</h3> <p>Retrospective case series (July 2009 to July 2023).</p> </section> <section> <h3> Setting</h3> <p>University teaching hospital.</p> </section> <section> <h3> Animals</h3> <p>Twenty-one client-owned dogs with hemostatic disorders, hemorrhage, or risk of procedure-related hemorrhage.</p> </section> <section> <h3> Interventions</h3> <p>None.</p> </section> <section> <h3> Measurements and Main Results</h3> <p>All dogs received homologous cryoprecipitate transfusion.</p> <p>Sixteen dogs had von Willebrand disease (one also had factor XI deficiency); three dogs had hemophilia A; and two dogs had normal concentration of von Willebrand factor and were not diagnosed with any hemostatic disorder. Sixteen dogs also received other blood products and/or hemostatic medications. Twenty-two cryoprecipitate transfusions were administered to 16 dogs before, during, or after surgery; 16 of those 22 transfusions were given to 14 dogs without evidence of hemorrhage but with history of bleeding disorder and/or previous hemorrhage with the aim of preventing hemorrhage. Eight transfusions were given to six dogs to control hemorrhage not associated with surgery. Sixteen dogs (18 transfusions) received cryoprecipitate prepared in-house. Five dogs (12 transfusions) received a commercial lyophilized cryoprecipitate. No dog developed any serious adverse reactions to cryoprecipitate transfusion. All dogs were discharged from the hospital (median, 2 days after cryoprecipitate transfusion [range, 1–25 days]). The benefits of cryoprecipitate transfusion could not be well documented because of the retrospective nature of this study and the concurrent administration of other blood products and/or hemostatic medications to 16 dogs.</p> </section> <section> <h3> Conclusions</h3> <p>Homologous cryoprecipitate transfusion appeared to be safe when administered for prevention or treatment of hemorrhage in dogs, but additional studies to assess safety and efficacy are warrante

目的：报道同源低温沉淀输注在有止血障碍、出血或出血风险的犬中，并报告与这些低温沉淀输注相关的不良反应。设计：回顾性病例系列（2009年7月至2023年7月）。单位：大学教学医院。动物：21只客户拥有的有止血障碍、出血或手术相关出血风险的狗。干预措施:没有。测量结果及主要结果：所有犬均接受同种低温沉淀输注。16只狗患有血管性血友病（1只也有因子XI缺乏症）；3只狗患A型血友病；2只血清血管性血友病因子正常，无止血障碍。16只狗还接受了其他血液制品和/或止血药物治疗。16只狗在手术前、手术中或手术后接受22次低温沉淀输注；在这22次输血中，有16次给了14只没有出血迹象但有出血性疾病史和/或先前出血的狗，目的是预防出血。对6只狗进行8次输血，以控制与手术无关的出血。16只狗（18次输血）接受室内制备的低温沉淀。5只狗（12次输血）接受商业冻干冷冻沉淀。没有狗对低温沉淀输注产生任何严重的不良反应。所有犬均出院（中位数为低温沉淀输注后2天[范围1-25天]）。由于本研究的回顾性性质以及同时给16只狗使用其他血液制品和/或止血药物，低温沉淀输血的益处无法得到很好的证明。结论：同源低温沉淀输血在预防或治疗犬出血时似乎是安全的，但需要进一步的研究来评估安全性和有效性。

{"title":"Retrospective Evaluation of Cryoprecipitate Transfusion in Dogs to Prevent or Treat Hemorrhage: 21 Cases (2009–2023)","authors":"W. Y. Eunice Lam, Linda G. Martin, K. Jane Wardrop, Jillian M. Haines","doi":"10.1111/vec.70045","DOIUrl":"10.1111/vec.70045","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To report homologous cryoprecipitate transfusions in dogs with hemostatic disorders, hemorrhage, or risk of hemorrhage, and to report adverse reactions associated with these cryoprecipitate transfusions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Retrospective case series (July 2009 to July 2023).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>University teaching hospital.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Animals</h3>\u0000 \u0000 <p>Twenty-one client-owned dogs with hemostatic disorders, hemorrhage, or risk of procedure-related hemorrhage.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interventions</h3>\u0000 \u0000 <p>None.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements and Main Results</h3>\u0000 \u0000 <p>All dogs received homologous cryoprecipitate transfusion.</p>\u0000 \u0000 <p>Sixteen dogs had von Willebrand disease (one also had factor XI deficiency); three dogs had hemophilia A; and two dogs had normal concentration of von Willebrand factor and were not diagnosed with any hemostatic disorder. Sixteen dogs also received other blood products and/or hemostatic medications. Twenty-two cryoprecipitate transfusions were administered to 16 dogs before, during, or after surgery; 16 of those 22 transfusions were given to 14 dogs without evidence of hemorrhage but with history of bleeding disorder and/or previous hemorrhage with the aim of preventing hemorrhage. Eight transfusions were given to six dogs to control hemorrhage not associated with surgery. Sixteen dogs (18 transfusions) received cryoprecipitate prepared in-house. Five dogs (12 transfusions) received a commercial lyophilized cryoprecipitate. No dog developed any serious adverse reactions to cryoprecipitate transfusion. All dogs were discharged from the hospital (median, 2 days after cryoprecipitate transfusion [range, 1–25 days]). The benefits of cryoprecipitate transfusion could not be well documented because of the retrospective nature of this study and the concurrent administration of other blood products and/or hemostatic medications to 16 dogs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Homologous cryoprecipitate transfusion appeared to be safe when administered for prevention or treatment of hemorrhage in dogs, but additional studies to assess safety and efficacy are warrante","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"35 5","pages":"564-570"},"PeriodicalIF":1.2,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/vec.70045","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Issue Information - Prelim 问题信息-初步

IF 1.2 3区农林科学 Q3 VETERINARY SCIENCES

Journal of veterinary emergency and critical care

Pub Date : 2025-10-06 DOI: 10.1111/vec.70037

引用次数: 0

Abstracts From the International Veterinary Emergency and Critical Care Symposium, and the European Veterinary Emergency and Critical Care Annual Congress 2025 摘要来自国际兽医急诊和重症监护研讨会，以及2025年欧洲兽医急诊和重症监护年会

IF 1.2 3区农林科学 Q3 VETERINARY SCIENCES

Journal of veterinary emergency and critical care

Pub Date : 2025-10-06 DOI: 10.1111/vec.70030

引用次数: 0

Issue Information - Prelim 问题信息-初步